- Review
Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article
- Chieh-Hsun Chen,
- Hsin-Su Yu and
- Sebastian Yu
Immune checkpoint inhibitors (ICIs) have emerged as novel options that are effective in treating various cancers. They are monoclonal antibodies that target cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cel...

